Activation of CD4 T cells during prime immunization determines the success of a therapeutic hepatitis B vaccine in HBV-carrier mouse models.

Su J, Brunner L, Oz EA, et al. Journal of Hepatology. Published online January 2023:S0168827822034651. doi:10.1016/j.jhep.2022.12.013

Share on linkedin
Share on reddit
Share on facebook
Share on twitter
Share on email